RI Defeats HEP C

If Dr. Lynn Taylor is successful, Hepatitis C, or Hep C, will no longer be a silent killer and an invisible plague in Rhode Island.

The symptoms of the chronic liver disease, which results from infection by hepatitis C virus, may not appear for many years; more than 70 percent of people with Hep C are unaware that they are infected.

(Distributed August 5, 2014)

PrEParing for an HIV Revolution

Two years ago on July 16, 2012, the Food & Drug Administration approved the first-ever pill to prevent HIV, known as pre-exposure prophylaxis (PrEP). To mark this occasion, the National Minority AIDS Council (NMAC) is thrilled to launch its PrEPare for Life program, including an online resource page and the first of its peer-based educational videos.

(Distributed July 30, 2014)

The Inaugural New England HIV Implementation Science Network Symposium

The inaugural New England HIV Implementation Science Network symposium was held on June 4, 2014. Attended by over 160 Network members from across New England, the meeting was the launch pad for a new collaboration between the Yale Center for Interdisciplinary Research on AIDS and the Lifespan/Tufts/Brown Center for AIDS Research on implementation science in small urban areas. Participants representing all six New England states included HIV/AIDS research scientists, advocates, health departments, and HIV service providers, as well as consumers and industry representatives.

(Distributed July 22, 2014)

Special HCV Issue of RI Medical Journal

For more than a century and a half, the Rhode Island Medical Society has published a journal for the physicians of the state.This issue of the Journal features articles on various aspects of the RI HCV epidemic. It addresses key domains including epidemiology, prevention, screening , treatment, public health policy and advocacy.

(Distributed July 2, 2014)

New CDC HIV Testing Recommendations Offer Faster Diagnosis

Ahead of National HIV Testing Day on June 27, the Centers for Disease Control and Prevention (CDC) is recommending a new approach for HIV testing in laboratories.

The new approach "capitalizes on the latest technology to improve diagnosis of acute infection, the earliest stage of HIV infection when people are most likely to transmit the virus," Jonathan Mermin, MD, MPH, director of the CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, said in a statement.

(Distributed July 1, 2014)
Syndicate content Subscribe via RSS feed